title: Reply to Calcagno et al.
authors: Jennifer A
authors: JA
authors: Kieran
authors: Susanne
authors: S
authors: Schmitz
authors: Aisling
authors: A
authors: O'Leary
authors: Cathal
authors: C
authors: Walsh
authors: Colm
authors: C
authors: Bergin
authors: Suzanne
authors: S
authors: Norris
authors: Michael G
authors: MG
authors: Barry
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use*; D011392:Proline / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011392:Proline